The Transcription Factor MEF/Elf4 Is Dually Modulated by p53-MDM2 Axis and MEF-MDM2 Autoregulatory Mechanism

被引:17
|
作者
Suico, Mary Ann [1 ]
Fukuda, Ryosuke [1 ]
Miyakita, Rui [1 ]
Koyama, Kosuke [1 ]
Taura, Manabu [1 ]
Shuto, Tsuyoshi [1 ]
Kai, Hirofumi [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan
关键词
MYELOID ELF-1-LIKE FACTOR; REGULATES LYSOZYME TRANSCRIPTION; PROMYELOCYTIC LEUKEMIA PROTEIN; TUMOR-SUPPRESSOR P53; EPITHELIAL-CELLS; FACTOR MEF; HUMAN BETA-DEFENSIN-2; HEMATOPOIETIC-CELLS; CARCINOMA CELLS; ENDOGENOUS P53;
D O I
10.1074/jbc.M114.580209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myeloid Elf-1-like factor (MEF) or Elf4 is an ETS transcription factor that activates innate immunity-associated genes such as lysozyme (LYZ), human beta-defensin 2 (H beta D2), and interleukin-8 (IL-8) in epithelial cells and is also known to influence cell cycle progression. MEF is transcriptionally activated by E2F1, but the E2F1-mediated transcriptional activation is inhibited by p53 through E2F1-p53 protein interaction. Although the transcriptional activation of MEF has been investigated in depth, its post-translational regulation is not well explored. By overexpressing MEF cDNA in human cell lines, here we show that MEF protein expression is suppressed by p53. By screening a number of E3 ligases regulated by p53, we found that MDM2 is involved in the effect of p53 on MEF. MDM2 is transcriptionally activated by p53 and interacts with MEF protein to enhance MEF degradation. MDM2 reduces MEF protein expression, as well as stability and function of MEF as transcriptional activator. Furthermore, MDM2 was able to down-regulate MEF in the absence of p53, indicating a p53-independent effect on MEF. Notably, MEF transcriptionally activates MDM2, which was previously demonstrated to be the mechanism by which MEF suppresses the p53 protein. These results reveal that in addition to the potential of MEF to down-regulate p53 by transcriptionally activating E3 ligase MDM2, MEF participates with MDM2 in a novel autoregulatory feedback loop to regulate itself. Taken together with the findings on the effect of p53 on MEF, these data provide evidence that the p53-MDM2-MEF axis is a feedback mechanism that exquisitely controls the balance of these transcriptional regulators.
引用
收藏
页码:26143 / 26154
页数:12
相关论文
共 50 条
  • [21] Targeting Post-Translational Regulation of p53 in Colorectal Cancer by Exploiting Vulnerabilities in the p53-MDM2 Axis
    Lai, Chunwei W.
    Xie, Cindy
    Raufman, Jean-Pierre
    Xie, Guofeng
    CANCERS, 2022, 14 (01)
  • [22] SMAR1 Forms a Ternary Complex with p53-MDM2 and Negatively Regulates p53-mediated Transcription
    Pavithra, Lakshminarasimhan
    Mukherjee, Srijata
    Sreenath, Kadreppa
    Kar, Sanchari
    Sakaguchi, Kazuyasu
    Roy, Siddhartha
    Chattopadhyay, Samit
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 388 (04) : 691 - 702
  • [23] Insight on Heterocycles as p53-MDM2 Protein-Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation
    Basha, N. Jeelan
    Mohan, R. M.
    CHEMISTRYSELECT, 2024, 9 (10):
  • [24] Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence
    Xiuhua Xu
    Qiao Liu
    Chen Zhang
    Shuai Ren
    Limei Xu
    Zixiao Zhao
    Hao Dou
    Peishan Li
    Xiyu Zhang
    Yaoqin Gong
    Changshun Shao
    Cell Death & Disease, 10
  • [25] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
    Grinkevich, Vera V.
    Vema, Aparna
    Fawkner, Karin
    Issaeva, Natalia
    Andreotti, Virginia
    Dickinson, Eleanor R.
    Hedstrom, Elisabeth
    Spinnler, Clemens
    Inga, Alberto
    Larsson, Lars-Gunnar
    Karlen, Anders
    Wilhelm, Margareta
    Barran, Perdita E.
    Okorokov, Andrei L.
    Selivanova, Galina
    Zawacka-Pankau, Joanna E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [26] Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence
    Xu, Xiuhua
    Liu, Qiao
    Zhang, Chen
    Ren, Shuai
    Xu, Limei
    Zhao, Zixiao
    Dou, Hao
    Li, Peishan
    Zhang, Xiyu
    Gong, Yaoqin
    Shao, Changshun
    CELL DEATH & DISEASE, 2019, 10 (4)
  • [27] p53-MDM2/MDM4相关抗肿瘤药物及其机制的研究进展
    王昱升
    李兵
    中国肿瘤生物治疗杂志, 2021, 28 (03) : 299 - 305
  • [28] Effective Targeting of the P53-MDM2 Axis in Preclinical Models of Infant MLL-Rearranged Acute Lymphoblastic Leukemia
    Richmond, Jennifer
    Carol, Hernan
    Evans, Kathryn
    High, Laura
    Mendomo, Agnes
    Robbins, Alissa
    Meyer, Claus
    Venn, Nicola C.
    Marschalek, Rolf
    Henderson, Michelle
    Sutton, Rosemary
    Kurmasheva, Raushan T.
    Kees, Ursula R.
    Houghton, Peter J.
    Smith, Malcolm A.
    Lock, Richard B.
    CLINICAL CANCER RESEARCH, 2015, 21 (06) : 1395 - 1405
  • [29] Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53
    Allende-Vega, N.
    Saville, M. K.
    Meek, D. W.
    ONCOGENE, 2007, 26 (29) : 4234 - 4242
  • [30] Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53
    N Allende-Vega
    M K Saville
    D W Meek
    Oncogene, 2007, 26 : 4234 - 4242